Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 22, Issue 1
Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Therapeutics/Prevention
Randomised controlled trial
Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa
Online download statistics by month:
Online download statistics by month: January 2017 to October 2024
Abstract
Full
Pdf
Jan 2017
286
16
51
Feb 2017
134
13
10
Mar 2017
94
12
15
Apr 2017
82
5
4
May 2017
45
16
10
Jun 2017
29
3
1
Jul 2017
62
6
3
Aug 2017
60
3
0
Sep 2017
79
1
0
Oct 2017
68
8
4
Nov 2017
63
8
5
Dec 2017
68
4
4
Jan 2018
49
2
2
Feb 2018
49
3
1
Mar 2018
51
4
0
Apr 2018
24
4
3
May 2018
54
1
1
Jun 2018
57
1
0
Jul 2018
55
0
0
Aug 2018
70
6
1
Sep 2018
35
0
1
Oct 2018
43
0
2
Nov 2018
60
6
3
Dec 2018
36
0
0
Jan 2019
40
3
0
Feb 2019
43
2
2
Mar 2019
35
3
5
Apr 2019
33
2
1
May 2019
34
2
0
Jun 2019
32
3
0
Jul 2019
33
2
0
Aug 2019
6
0
0
Sep 2019
16
0
0
Oct 2019
38
2
2
Nov 2019
24
1
0
Dec 2019
22
0
0
Jan 2020
28
0
0
Feb 2020
23
2
2
Mar 2020
20
2
3
Apr 2020
8
2
0
May 2020
21
1
1
Jun 2020
20
1
0
Jul 2020
24
2
1
Aug 2020
13
0
0
Sep 2020
27
0
0
Oct 2020
19
1
1
Nov 2020
10
0
0
Dec 2020
6
0
0
Jan 2021
23
1
0
Feb 2021
17
1
1
Mar 2021
18
0
0
Apr 2021
18
0
0
May 2021
2
0
0
Jun 2021
2
2
0
Jul 2021
3
2
0
Aug 2021
1
0
1
Sep 2021
2
2
0
Oct 2021
23
0
1
Nov 2021
48
1
0
Dec 2021
22
1
0
Jan 2022
12
3
1
Feb 2022
32
0
0
Mar 2022
25
0
0
Apr 2022
28
0
0
May 2022
51
0
0
Jun 2022
61
3
0
Jul 2022
24
0
0
Aug 2022
55
1
0
Sep 2022
48
2
3
Oct 2022
42
8
1
Nov 2022
50
1
1
Dec 2022
34
2
2
Jan 2023
26
2
0
Feb 2023
62
0
0
Mar 2023
20
2
1
Apr 2023
2
0
0
May 2023
24
2
1
Jun 2023
117
0
0
Jul 2023
43
0
1
Aug 2023
14
2
1
Sep 2023
44
2
0
Oct 2023
20
0
0
Nov 2023
35
4
2
Dec 2023
28
1
1
Jan 2024
27
2
0
Feb 2024
30
1
1
Mar 2024
28
0
0
Apr 2024
46
0
0
May 2024
24
0
0
Jun 2024
57
1
0
Jul 2024
31
1
0
Aug 2024
31
1
1
Sep 2024
31
1
1
Oct 2024
25
0
0
Total
3634
205
160
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?